Plant closure as Micro Therapeutics focuses on US:
This article was originally published in Clinica
Executive Summary
Micro Therapeutics has laid off 60 workers and closed its facility in Bochum, Germany, shifting all production to its headquarters in Irvine, California. The company, which makes catheter and interventional neuroradiology products, says the move is designed to cut manufacturing and overhead costs, and improve customer services. It will incur fourth-quarter one-off charges of $2.5-3.5m as a result of the closure.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.